Q4 2023 Holdings
Filed 2024-02-13 | 82 holdings | $547.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $41.6M | 1,404,608 | 7.6% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $31.8M | 750,000 | 5.8% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $25.8M | 1,090,441 | 4.7% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $23.1M | 100,000 | 4.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $21.2M | 460,000 | 3.9% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $20.6M | $17,000,000 | 3.8% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $19.8M | 1,900,000 | 3.6% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $18.9M | 340,000 | 3.4% |
| Lianbio | SPONSORED ADS | 53000N108 | $16.9M | 3,779,694 | 3.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $15.9M | 447,095 | 2.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $15.9M | 400,000 | 2.9% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $15.0M | 537,093 | 2.7% |
| Teva Pharmaceutical Inds LTD(TEVA)Call | SPONSORED ADS | 881624209 | $14.6M | 1,400,000 | 2.7% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $14.5M | 345,000 | 2.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $13.4M | 160,000 | 2.4% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $12.9M | 175,000 | 2.4% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $11.3M | 1,466,465 | 2.1% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $11.2M | 563,824 | 2.0% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $11.1M | 517,554 | 2.0% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $10.0M | 1,550,408 | 1.8% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $9.9M | 356,384 | 1.8% |
| Inozyme Pharma Inc | COM | 45790W108 | $8.0M | 1,885,802 | 1.5% |
| Eyepoint Pharmaceuticals Inc(EYPT)Put | COM NEW | 30233G209 | $7.4M | 320,100 | 1.4% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $7.1M | 690,112 | 1.3% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $6.3M | 795,729 | 1.2% |
| Establishment Labs Hldgs Inc(ESTA) | COM | G31249108 | $5.9M | 228,277 | 1.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $5.9M | 100,049 | 1.1% |
| Establishment Labs Hldgs Inc(ESTA)Call | COM | G31249108 | $5.8M | 225,000 | 1.1% |
| Alnylam Pharmaceuticals Inc(ALNY)Call | COM | 02043Q107 | $5.7M | 30,000 | 1.0% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $5.6M | 500,000 | 1.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $5.6M | 300,000 | 1.0% |
| Savara Inc(SVRA) | COM | 805111101 | $5.4M | 1,150,000 | 1.0% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $4.8M | 550,000 | 0.9% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $4.5M | 75,000 | 0.8% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $4.3M | 70,988 | 0.8% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $4.2M | 300,000 | 0.8% |
| Structure Therapeutics Inc(GPCR)Call | SPONSORED ADS | 86366E106 | $4.1M | 100,000 | 0.7% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $4.0M | 60,000 | 0.7% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $4.0M | 50,000 | 0.7% |
| Springworks Therapeutics Inc | COM | 85205L107 | $3.7M | 100,000 | 0.7% |
| Omeros Corp | NOTE 5.250% 2/1 | 682143AG7 | $3.6M | $6,000,000 | 0.7% |
| Coherus Biosciences Inc | NOTE 1.500% 4/1 | 19249HAB9 | $3.4M | $6,000,000 | 0.6% |
| Crinetics Pharmaceuticals in(CRNX)Put | COM | 22663K107 | $3.4M | 94,300 | 0.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $3.3M | 300,000 | 0.6% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $3.2M | 80,000 | 0.6% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $3.1M | 25,000 | 0.6% |
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $3.1M | 300,000 | 0.6% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $3.0M | 300,274 | 0.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $2.9M | 7,500 | 0.5% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $2.8M | 191,535 | 0.5% |